Connect with us

News

How can tech improve life for endometriosis sufferers?

Published

on

Endometriosis is a condition affecting women of any age, where tissue similar to the lining of the womb starts to grow in other places, such as the ovaries and fallopian tubes.

It’s a long-term condition which is often accompanied by a number of debilitating symptoms, including tummy, back or pelvic pain, pain during or after sex, and nausea, constipation, diarrhoea, or blood in urine during menstruation.

It can also cause fertility issues, with sufferers having difficulty getting pregnant.

There is no cure for endometriosis as yet, although there are treatments that can help.

And, with the rise in femtech, there are a number of technological advances that can help manage the condition and its symptoms. Femtech World looks at the latest innovations…

Diagnostic support

Like many other women’s health conditions, endometriosis is under-researched, under-served and under-funded.

This has the knock-on effect of making it little understood, by patients and clinicians alike, meaning diagnosis is often missed; in fact, according to Endometriosis UK, it takes an average of 7.5 years to get diagnosed.

The delay in diagnosis, along with the current care experience, was the catalyst behind Syrona Health’s SORA app.

Syrona is a femtech firm co-founded by Chantelle Bell and Anya Roy, who met at the University of Cambridge, to support women’s health, with a particular focus on gynaecological issues.

Last year, the firm launched the SORA app to allow women to track their endometriosis and other health symptoms such as mood, exercise and sleep, as well as giving them access to a patient community, and doctor-approved insights.

To increase engagement and retention, the app also features an element of gamification. Users can collect points for tracking their symptoms, which can be exchanged for premium products and services. Hormone test kits, while not endometriosis-specific, can also help answer fertility-related questions, which are often a major concern for women living with endometriosis.

Endodiag is a French startup which is working on a new endometriosis diagnostic solution called EndoSearch.

The non-invasive diagnostic test can assess the presence of endometriosis without surgery, which may lead to a quicker, easier diagnosis. The company aims to diagnose better, provide more personalised assistance, and more efficient treatment options and fertility strategies.

Better understanding

Endometriosis, its causes and its triggers are little understood, despite affecting as many as one in 10 women.

However, Philippa Saunders and Andrew Horne, founders and co-directors of the EXPPECT Centre for Pelvic Pain and Endometriosis at the university, believe that using ‘smart’ technologies could create a better understanding of the condition.

In a new study, the team will consider the benefits of combining a wearable, clinical-grade biosensor with a mobile phone app where patients can provide information about their symptoms, helping researchers to gather objective and detailed data to monitor and assess patients’ physical activity, sleep and other everyday behaviours.

Such information could then be used to develop further treatments and options for endometriosis sufferers.

Pain relief

One of the main symptoms of endometriosis is pain, either in the back, tummy or pelvis, which may be worse during menstruation.

Currently, the only accepted method of relieving the pain is through traditional over-the-counter painkillers, but many women, understandably, are reluctant to take these too regularly.

Ovira was created to offer a new solution to endometriosis and also period pain, using Transcutaneous Electrical Nerve Stimulation (TENS) technology.

The tech works by overloading the user’s nervous system in order to reduce its ability to transmit pain signals to the brain.

The firm has created a small, wearable and reusable TENS device called Noha; small pads that are attached to the wearer’s abdomen or back and transmit electrical signals to block the pain.

It is cost-efficient and drug-free, with no known side effects, making it a realistic option for women who don’t want to rely on OTC drugs.

Period tracking

While menstrual trackers cannot help with the pain of endometriosis, they can help women feel more in control of their cycles, meaning they can plan around their symptoms, as well as arming them with enough information for a diagnosis.

The most well-known of these is probably Clue, which allows users to track the following symptoms, which may be of use for managing the condition:

  • Bleeding patterns (including spotting)
  • Pain
  • Menstrual heaviness
  • Energy
  • Bowel habits
  • Gastrointestinal symptoms
  • Contraception use

All of the above can help women build up a fuller picture of their symptoms, when they happen and how to manage them. It can also be useful evidence ahead of a diagnosis, to speed up the process.

Endometriosis is often seen as a silent condition, with little research and information available, and many women ascribing symptoms to ‘just’ their normal menstrual cycle.

However, the world of femtech, which is led largely by innovative female entrepreneurs, is looking to chance that, giving endo sufferers a voice.

 

Continue Reading
2 Comments

2 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Adolescent health

Newly-launched Female Health Hub will support grassroots football players

Published

on

A new Female Health Hub launched by the English FA will support women and girls in grassroots football in England with trusted advice on health issues affecting play.

The hub brings together expert-backed guidance, practical tools and player insights in one place, giving women and girls practical advice and reassurance on female health in football.

It has four core aims: to help women and girls better understand their bodies and how female health affects performance and participation, to educate players on key health topics and when to seek further advice or support, to provide practical strategies to help navigate common female health challenges, and to help break down taboos and normalise conversations around female health in football.

Users of the hub will also be able to hear directly from members of the England women’s national team, who share their own experiences of navigating female health matters while playing at the highest level of the game.

“Our ambition is to create a game where women and girls can thrive,” said Sue Day, the FA’s director of women’s football.

“To achieve that, it’s essential that players feel supported in environments that understand and respond to their female health needs.

“We’ve heard directly from grassroots players that they want better information and support around female health, but that they often don’t know where to find it.

“The launch of the Female Health Hub marks an important step in changing the landscape.

“We want every player to feel confident in her own skin and supported without judgment, so she can feel empowered by her body, rather than held back by it.”

The platform was launched following research conducted by the FA that highlighted the need for better education and support around female health in football.

According to the FA, 88 per cent of adult players surveyed said their menstrual cycle has an impact on their ability to train or play, but 86 per cent reported they had never received education about the menstrual cycle in relation to football performance and training.

The research also found 64 per cent of women experience issues related to sports bras or breast health while playing football, despite sports bras being considered one of the most important pieces of playing kit.

Players also expressed strong interest in learning more about injury prevention, at 87 per cent, nutrition, at 84 per cent, and mental health, at 77 per cent, in relation to female health.

The first phase of the Female Health Hub focuses on three of the most requested topics: menstrual health, breast health and injury resilience, with further content to follow, including nutrition and pelvic health guidance.

Continue Reading

Pregnancy

Women’s health strategy a ‘missed opportunity,’ RCM says

Published

on

The Royal College of Midwives (RCM) has referred to the women’s health strategy as a ‘missed opportunity’ to address maternity services. 

The renewed strategy was released by the government this week, with the aim of putting women’s experiences at the centre of care and ensuring they are “better heard and served”.

However, the government stated that because of ongoing investigations into maternity services across the country, the strategy “does not seek to address safety in maternity and neonatal services”.

The RCM described this as a “missed opportunity” and urged the government to ensure that, following the inquiries, maternity is placed “at the very heart” of the strategy.

Gill Walton, RCM chief executive, said the college was “deeply disappointed” that maternity services “do not feature as a headline priority” in the renewed strategy.

She said: “This is a significant missed opportunity and one that is very difficult to understand.

“Pregnancy, birth and the postnatal period are not a footnote in women’s health – they are one of the most significant and consequential phases of a woman’s life.

“A strategy that treats maternity as an afterthought is not truly a women’s health strategy at all. It is exactly the kind of thinking that has allowed maternity services to reach the point they are at today.”

Walton acknowledged that the strategy contained commitments on ensuring women’s voices shape their care, on supporting families through pregnancy loss and on the principle that services should be held accountable when they fail to listen to women.

She added: “But a strategy that addresses one part of women’s health while leaving maternity care behind is only doing half the job.”

Walton urged the government to ensure that this is addressed when the ongoing investigations into maternity care conclude, with any recommendations placed “at the very heart of this strategy with the seriousness and urgency that women, families and midwives deserve”.

In the foreword to the renewed plans, health and social care secretary Wes Streeting referred to the ongoing independent National Maternity and Neonatal Investigation as action being taken by the government to improve safety in maternity services.

The strategy also refers to the new National Maternity and Neonatal Taskforce, chaired by Streeting, which aims to help deliver “safer, more equitable care” for women, babies and families.

The foreword said that, because of ongoing initiatives, it was “important that this work continues without restriction and that the government can properly respond to the findings”.

It added: “This renewed women’s health strategy therefore does not seek to address safety in maternity and neonatal services other than that related to women’s health before and during pregnancy and the actions we are taking immediately to improve maternity and neonatal care.”

The strategy does, however, include plans to prioritise health education in schools, communities and healthcare settings to “empower women” with the “knowledge and tools they need to help control their fertility” and “prepare for the best pregnancy outcomes.

It also promises to provide women with access to “safe and high-quality contraception, abortion care, fertility services, preconception care and support after pregnancy loss in convenient settings.

Continue Reading

Fertility

Genetic carrier screening before pregnancy: What to know

Published

on

Article produced in association with London Pregnancy Clinic and Jeen Health

For the majority of couples planning a pregnancy, genetic testing is not something they think about until a problem arises.

Pre-conception genetic carrier screening challenges this approach by identifying risk before pregnancy begins.

As panel sizes have grown and at-home testing options have become widely available, carrier screening is transitioning from a niche clinical referral into a mainstream component of reproductive planning.

What Carrier Screening Tests For

Being a carrier of a genetic condition means carrying one copy of a variant in a gene associated with that condition, without being affected by it.

In most cases, carriers are entirely unaware of their status.

The clinical significance of carrier status emerges when both members of a couple carry a variant in the same gene: in this scenario, each pregnancy carries a one in four chance of resulting in a child who inherits two copies of the variant and is affected by the condition.

The conditions most frequently included in expanded carrier screening panels include cystic fibrosis, spinal muscular atrophy (SMA), fragile X syndrome, sickle cell disease, and a range of metabolic and enzyme deficiency disorders.

The Beacon 787 carrier test, offered by Jeen Health, screens for 787 conditions from a single sample, making it one of the most comprehensive panels currently available to UK families.

Who Is Most Likely to Benefit

Any couple planning a pregnancy can consider carrier screening. It is particularly relevant for:

  • Couples with a family history of a known inherited condition
  • Those from populations with higher carrier frequencies for specific conditions, including Ashkenazi Jewish, South Asian and African communities
  • Couples pursuing fertility treatment, where genetic information informs treatment planning
  • Those who wish to have the most complete picture of their reproductive health before conception

Importantly, being a carrier of a condition does not mean a child will be affected. It means there is a defined statistical risk that can be quantified, discussed and planned for with appropriate clinical support.

How the Test Is Performed

Carrier screening is typically carried out on a blood or saliva sample.

For at-home options such as the testing offered by Jeen Health, a cheek swab collection kit is dispatched to the patient, the sample is returned by post, and results are delivered digitally within a defined turnaround period.

In-clinic carrier testing may use a blood draw and provides the advantage of immediate access to a clinical consultation at the point of result delivery.

London Pregnancy Clinic offers genetics counselling through its partnership with Jeen Health, allowing couples to receive and contextualise carrier test results with expert support.

Genetic counselling before and after testing is recommended by Genomics England as a standard component of any genomic testing pathway.

What Happens If Both Partners Are Carriers

If both partners are identified as carriers for the same autosomal recessive condition, they are typically offered further counselling to discuss their options.

These may include proceeding naturally with an awareness of the risk, using prenatal diagnosis (CVS or amniocentesis) during pregnancy to test the fetus, or pursuing preimplantation genetic testing (PGT) in the context of IVF, which allows unaffected embryos to be selected before transfer.

The purpose of identifying carrier status before pregnancy is to give couples time to consider these options without the added pressure of an ongoing pregnancy.

Knowledge of carrier status does not remove reproductive choices; it expands the information available when making them.

The Role of Pre-Conception Services

Carrier screening sits within a broader category of pre-conception care that includes fertility assessments, general health optimisation and, where relevant, management of existing conditions before pregnancy begins.

London Pregnancy Clinic offers pre-conception services encompassing fertility investigations, genetics counselling and carrier testing as part of an integrated 0th trimester approach, allowing couples to address genetic and clinical risk factors before their pregnancy starts rather than after.

Disclaimer: This article is produced for informational purposes only and does not constitute medical advice, diagnosis or treatment.

Clinical guidance referenced reflects published NHS, NICE and RCOG standards as at March 2026. Individual circumstances vary; readers are advised to consult a qualified healthcare professional before acting on any information in this article.

This piece was produced in association with London Pregnancy Clinic and Jeen Health, which provided background clinical information for editorial purposes.

Hyperlinks to external sources are included for reference only and do not represent an endorsement of any product, service or organisation.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.